What are you
looking for?

Taking innovations to industrial scale

Changes in Siegfried’s Management Team

Wolfgang Wienand is stepping down as Chief Executive Officer of Siegfried and will join Lonza in summer 2024. The Board of Directors of Siegfried has appointed CFO Reto Suter as CEO ad interim. He will assume this additional responsibility as of May 1st, 2024. The search for the new Siegfried CEO has been initiated.

Read the media release

Siegfried is a leading contract development and manufacturing organization with a global network of 12 production sites on three continents. With 150 years of pharmaceutical and chemical experience, we are taking your innovations to industrial scale.

Our offering

As a globally leading contract development and manufacturing organization, we produce pharmaceutical ingredients and finished products as an integrated supplier.

Bringing together our long-standing pharma and chemical heritage

Learn more

Latest news

See all news
Ad hoc
Media Release Apr 02, 2024
Changes in Siegfried’s Management Team
Ad hoc
Media Release Feb 20, 2024
Siegfried continues to deliver profitable growth
Media Release Feb 02, 2024
Changes in Siegfried’s Senior Management Team
Media Release Dec 13, 2023
Siegfried confirmed in the Dow Jones Sustainability Index Europe for the third consecutive year
Ad hoc
Media Release Aug 17, 2023
Siegfried delivers strong sales growth and profitability in first half 2023
Media Release May 15, 2023
Changes in Siegfried’s Executive Committee
Ad hoc
Media Release May 04, 2023
Siegfried acquires majority stake in DINAMIQS to establish a best-in-class development and manufacturing organization for cell and gene therapies
Media Release Apr 25, 2023
Siegfried begins construction of a new global R&D Center for Drug Substances in Evionnaz
Media Release Apr 20, 2023
Siegfried increases distribution and ap­points new board member
Media Release Mar 09, 2023
Siegfried opens global Development Center for Drug Products in Barcelona
Ad hoc
Media Release Feb 22, 2023
On the move since 150 years: Siegfried significantly increases sales and profits in 2022
Media Release Feb 06, 2023
Siegfried appoints Christian Dowdeswell as Chief Business Officer Drug Substances
To top